Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1989-10-12
pubmed:abstractText
D1 dopamine receptors were identified in membranes of human nucleus caudatus, nucleus accumbens, amygdala, and globus pallidus, by the specific binding of [3H](+)-R-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-benzazepine-7 -ol [( 3H]SCH 23390). In these four brain regions, dopamine/[3H]SCH 23390 competition binding curves were computer-analyzed to a two-site model, distinguishing a high- (RH) and low- (RL) affinity site for dopamine. The ability of guanine nucleotides (0.4 mM GTP or 0.1 mM 5'-guanylylimidodiphosphate) to provoke a conversion of RH into RL was different between these brain regions. In amygdala, a complete conversion was seen, whereas there was no guanine nucleotide-effect on RH in globus pallidus. In nucleus caudatus and nucleus accumbens, guanine nucleotides provoked only a partial conversion of RH into RL, suggesting that these brain regions may contain guanine nucleotide-sensitive and -insensitive receptors. Heating of the membranes at 60 degrees C for 5 min had the same effect as guanine nucleotides. The pharmacological profiles of the guanine nucleotide-sensitive and -insensitive D1 receptors were similar, suggesting that D1 receptors in human brain are heterogeneous only with respect to their effector-coupling mechanism: guanine nucleotide-sensitive receptors, which are capable of undergoing functional coupling with Gs, and guanine nucleotide-insensitive receptors, which are not.(ABSTRACT TRUNCATED AT 250 WORDS)
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-3042
pubmed:author
pubmed:issnType
Print
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1096-102
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:2527968-Aged, pubmed-meshheading:2527968-Aged, 80 and over, pubmed-meshheading:2527968-Amygdala, pubmed-meshheading:2527968-Autoradiography, pubmed-meshheading:2527968-Benzazepines, pubmed-meshheading:2527968-Brain, pubmed-meshheading:2527968-Caudate Nucleus, pubmed-meshheading:2527968-Cerebral Infarction, pubmed-meshheading:2527968-Dopamine, pubmed-meshheading:2527968-Dopamine Antagonists, pubmed-meshheading:2527968-Female, pubmed-meshheading:2527968-Globus Pallidus, pubmed-meshheading:2527968-Guanosine Triphosphate, pubmed-meshheading:2527968-Hot Temperature, pubmed-meshheading:2527968-Humans, pubmed-meshheading:2527968-Kinetics, pubmed-meshheading:2527968-Male, pubmed-meshheading:2527968-Middle Aged, pubmed-meshheading:2527968-Nucleus Accumbens, pubmed-meshheading:2527968-Organ Specificity, pubmed-meshheading:2527968-Receptors, Dopamine, pubmed-meshheading:2527968-Receptors, Dopamine D1, pubmed-meshheading:2527968-Reference Values, pubmed-meshheading:2527968-Tritium
pubmed:year
1989
pubmed:articleTitle
In human brain two subtypes of D1 dopamine receptors can be distinguished on the basis of differences in guanine nucleotide effect on agonist binding.
pubmed:affiliation
Department of Neurology, Akademisch Ziekenhuis, Vrije Universiteit Brussel, Belgium.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't